Showing results (161-170 of 403) with videos related to

Sort By:
Pageof 41
Oncogene|August 22, 2000
Redox regulation of p53 during hypoxiaN S Chandel, M G Vander Heiden, C B Thompson, et al.
The Journal of Biological Chemistry|March 25, 1992
AU RNA-binding factors differ in their binding specificities and affinitiesP R Bohjanen, B Petryniak, C H June, et al.
American Journal of Physiology. Cell Physiology|February 15, 2001
Glucocorticoids increase sodium pump alpha(2)- and beta(1)-subunit abundance and mRNA in rat skeletal muscleC B Thompson, I Dorup, J Ahn, et al.
Molecular and Cellular Biology|April 25, 2000
Role of oxidative phosphorylation in Bax toxicityM H Harris, M G Vander Heiden, S J Kron, et al.
Molecular and Cellular Biology|April 21, 2001
Characterization of XIAP-deficient miceH Harlin, S B Reffey, C S Duckett, et al.
Molecular Cell|March 17, 1999
Bcl-xL prevents cell death following growth factor withdrawal by facilitating mitochondrial ATP/ADP exchangeM G Vander Heiden, N S Chandel, P T Schumacker, et al.
Comptes Rendus De L'Academie Des Sciences. Serie III, Sciences De La Vie|May 1, 1995
Presence of the long and the short forms of Bcl-X in several human and murine tissuesJ F Rouayrenc, L H Boise, C B Thompson, et al.
Science (New York, N.Y.)|April 21, 1989
Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathwayT Lindstein, C H June, J A Ledbetter, et al.
International Immunology|July 1, 1993
Excision products of TCR V alpha recombination contain in-frame rearrangements: evidence for continued V(D)J recombination in TCR+ thymocytesW T McCormack, M Liu, C Postema, et al.
The Journal of Clinical Investigation|March 1, 1991
Guanine ribonucleotide depletion inhibits T cell activation. Mechanism of action of the immunosuppressive drug mizoribineL A Turka, J Dayton, G Sinclair, et al.
Pageof 41